Cargando…

TESC Promotes TGF-α/EGFR-FOXM1-Mediated Tumor Progression in Cholangiocarcinoma

Cholangiocarcinoma is a relatively uncommon but highly lethal malignancy. Improving outcomes in patients depends on earlier diagnosis and appropriate treatment; however, no satisfactory diagnostic biomarkers or targeted therapies are currently available. To address this shortcoming, we analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Cheng-Han, Chu, Cheng-Ying, Lin, Sey-En, Yang, Yu-Chen S.H., Chang, Hung-Shu, Yen, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281536/ https://www.ncbi.nlm.nih.gov/pubmed/32365487 http://dx.doi.org/10.3390/cancers12051105

Ejemplares similares

Validation of the Tunisian Empathy Scale for Children (TESC) in General Population and Children With Autism Spectrum Disorder
por: Ben Youssef, Hela, et al.
Publicado: (2022)

Long non-coding ROR promotes the progression of papillary thyroid carcinoma through regulation of the TESC/ALDH1A1/TUBB3/PTEN axis
por: Fan, Yuxia, et al.
Publicado: (2022)

Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway
por: Lin, Hung-Yun, et al.
Publicado: (2018)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021)

FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021)

Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma
por: Liu, Lingyun, et al.
Publicado: (2018)

FoxM1 drives ADAM17/EGFR activation loop to promote mesenchymal transition in glioblastoma
por: Zhang, Chunli, et al.
Publicado: (2018)

Long non-coding RNA TUG1/microRNA-187-3p/TESC axis modulates progression of pituitary adenoma via regulating the NF-κB signaling pathway
por: Zhang, Rui, et al.
Publicado: (2021)

FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression
por: Hu, Guohui, et al.
Publicado: (2019)

FoxM1 Promotes Glioma Cells Progression by Up-Regulating Anxa1 Expression
por: Cheng, Shi-Xiang, et al.
Publicado: (2013)

Aberrant ASPM expression mediated by transcriptional regulation of FoxM1 promotes the progression of gliomas
por: Zeng, Wen‐Jing, et al.
Publicado: (2020)

FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2018)

FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
por: Ai, Chao, et al.
Publicado: (2020)

FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

USP21 Promotes the Progression of Nasopharyngeal Carcinoma by Regulating FOXM1
por: Li, Xiaofeng, et al.
Publicado: (2023)

ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1
por: Jiao, Xiaodong, et al.
Publicado: (2018)

Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021)

NNMT promotes the progression of intrahepatic cholangiocarcinoma by regulating aerobic glycolysis via the EGFR-STAT3 axis
por: Lu, Shounan, et al.
Publicado: (2022)

SUN-025 Thyroid Hormone Suppresses FOXM1 Expression to Reduce Liver Cancer Progression
por: Lin, Kwang-Huei, et al.
Publicado: (2019)

Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells
por: Chan-on, Waraporn, et al.
Publicado: (2015)

FOXM1 Regulated by ERK Pathway MediatesTGF-β1-Induced EMT in NSCLC
por: Kong, Fei-Fei, et al.
Publicado: (2014)

FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription
por: Liu, Youhong, et al.
Publicado: (2017)

Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)

Unveiling resistance mechanisms to EGFR inhibitors in cholangiocarcinoma
por: Vaquero, Javier, et al.
Publicado: (2018)

TGFα-EGFR pathway in breast carcinogenesis, association with WWOX expression and estrogen activation
por: Pospiech, Karolina, et al.
Publicado: (2022)

A narrative review of research progress on FoxM1 in breast cancer carcinogenesis and therapeutics
por: Zhang, Yan-Ling, et al.
Publicado: (2021)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR
por: Lau, T-S, et al.
Publicado: (2017)

Chemoresistant fibroblasts dictate neoadjuvant chemotherapeutic response of head and neck cancer via TGFα-EGFR paracrine signaling
por: Su, Liangping, et al.
Publicado: (2023)

A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis
por: Wang, Yi-Wei, et al.
Publicado: (2022)

Aberrantly high activation of a FoxM1–STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers
por: Liu, Jun, et al.
Publicado: (2021)

Overexpression of EGFR and TGFα in von Hippel–Lindau-Related Central Nervous System Hemangioblastomas
por: Liu, Zhen, et al.
Publicado: (2020)

Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma
por: Wu, Wen-Sheng, et al.
Publicado: (2022)

Regulation of the master regulator FOXM1 in cancer
por: Liao, Guo-Bin, et al.
Publicado: (2018)

Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
por: Nishii, Kazuya, et al.
Publicado: (2021)

Progress in Radiotherapy for Cholangiocarcinoma
por: Wang, Ningyu, et al.
Publicado: (2022)

Terminal fucose mediates progression of human cholangiocarcinoma through EGF/EGFR activation and the Akt/Erk signaling pathway
por: Indramanee, Somsiri, et al.
Publicado: (2019)

FOXM1 regulates glycolysis and energy production in multiple myeloma
por: Cheng, Yan, et al.
Publicado: (2022)

Precision Medicine in Cholangiocarcinoma: Past, Present, and Future
por: Cheng, Chi-Yuan, et al.
Publicado: (2022)

Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma
por: Hong, Xuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qejghfp599h4qro6h3kr5en4me